s, France, from January 29-31, 2026. The survey found that over 50% of women learned about the effects of menopause on the skin by going through it themselves, with most finding out about it in their 40s.2However, over 30% would have liked to learn about this in their 30s and over 50% are at best neutral or dissatisfied with their knowledge on the topic.2

To address this knowledge gap, Galderma will leverage its expertise in dermatology to advance awareness, understanding, education, and treatment approaches for menopause-related skin changes. With around 85% of aesthetic patients being female, it is important to understand how these treatments can support women at all stages of life, especially during the complex time of the menopause.3To help advance this understanding, Galderma has made the pioneering decision to now include menopausal status in its clinical trials to provide critical insights into how its injectable aesthetic treatments can best serve this patient populat
=*=*=*=*=*=
当前为第2/14页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页